sellWeak cluster of 310b5-1 plan
Thomas Ciulla sold $3,515 of CLSD
Chief Medical Officer at Clearside Biomedical, Inc.. 2,170 shares at an average of $1.62, traded Jan 10, 2023, filed Jan 11, 2023.
Warning score
10Value
$3,515
2,170 shares
Holdings after
305,590
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$4k at market
- 0Share of holdings soldSold 0.7% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001209191-23-002993, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 10, 2023 | SOpen-market sale Common Stock10b5-1 | -2,170 | $1.62 | $3,515 | 305,590 | Jan 11, 2023 |
Related signals
Other insiders at Clearside Biomedical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | CLSDbuy Clearside Biomedical, Inc. | Clay Thorp director | $14k 15,000 shares | +9% | |
| 31Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $37k 36,500 shares | +57% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $25k 23,500 shares | +59% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Benjamin R Yerxa director | $10k 7,813 shares | +77% | |
| 34Weak | CLSDbuy Clearside Biomedical, Inc. | Anthony S Gibney director | $130k 100,000 shares | - | |
| 30Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong CHIEF MEDICAL OFFICER | $48k 30,000 shares | - | |
| 24Weak | CLSDbuy Clearside Biomedical, Inc. | Bradford T Whitmore owner | $600k 444,444 shares | +11% | |
| 30Weak | Clearside Biomedical, Inc. | Charles A. Deignan Chief Financial Officer | $17k 12,900 shares | -3% | |
| 33Weak | Clearside Biomedical, Inc. | George M Lasezkay CEO | $23k 18,000 shares | -4% | |
| 12Weak | CLSDbuy Clearside Biomedical, Inc. | Bradford T Whitmore owner | $100k 135,778 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.